Analyst Research Report Snapshot


Peel Hunt: EMIS Group (Buy) - Clear route to a strategic premium




Peel Hunt


24 Apr 2014





Companies referenced:


Available for Immediate Download

EMIS Group (Buy) Clear route to a strategic premium EMIS is uniquely positioned in the UK healthcare IT market to leverage the trend towards inter-operability across multiple care settings. This note explains the favourable NHS structures and frameworks now in place and EMIS’s alignment with key mandates and funding flows. We also discuss emerging uses of big data in the healthcare market, where we see long-term opportunities to add new revenue streams. We recommend a Buy on a sector discount and attractive free cash flow and dividend yields of 6% and 3% respectively, and we see good prospects for the company to build a strategic premium.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.